Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹70 Cr
P/E Ratio
10.12
P/B Ratio
1.03
Industry P/E
97.96
Debt to Equity
1.35
ROE
4.79 %
ROCE
9.97 %
Div. Yield
0 %
Book Value
38.23
EPS
4.63
CFO
₹85.52 Cr
EBITDA
₹124.00 Cr
Net Profit
₹26.74 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Vivo Bio Tech
| 5.74 | 5.14 | -21.35 | -13.85 | -2.11 | 5.86 | -- |
|
BSE Healthcare
| -7.27 | -1.01 | -0.76 | 19.87 | 19.29 | 22.12 | 9.77 |
|
BSE Small Cap
| -12.38 | 0.32 | -4.19 | 2.45 | 17.96 | 35.18 | 15.87 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Vivo Bio Tech
| 8.98 | 11.82 | -56.98 | 23.34 | 89.25 | -60.30 | 40.79 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 206.12 | 3,216.41 | -- | -1.72 | |
| 62.00 | 18.94 | 48.94 | 10.52 | |
| 113.17 | 403.30 | 97.96 | 4.89 | |
| 8.55 | 127.22 | -- | -- |
No Review & Analysis are available.
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vitro, in vivo, toxicity studies, pharmacological investigations, pharmacokinetic... and toxico kinetic studies, genotoxicity screening, analytical services, etc. It also supplies SPF lab animals. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India. Read more
Incorporated
1987
Chairman
--
Managing Director
--
Headquarters
Hyderabad, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Vivo Bio Tech Ltd stood at ₹ 128 Cr as on 31-Dec-24
The share price of Vivo Bio Tech Ltd is ₹39.26 (BSE) as of 25-Apr-2025 IST. Vivo Bio Tech Ltd has given a return of -2.11% in the last 3 years.
Vivo Bio Tech Ltd has a market capitalisation of ₹ 70 Cr as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Vivo Bio Tech Ltd is 1.03 times as on 25-Apr-2025, a 0% premium to its peers’ median range of 1.03 times.
The P/E ratio of Vivo Bio Tech Ltd is 10.12 times as on 25-Apr-2025, a 90% discount to its peers’ median range of 97.96 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Vivo Bio Tech Ltd and enter the required number of quantities and click on buy to purchase the shares of Vivo Bio Tech Ltd.
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vitro, in vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxico kinetic studies, genotoxicity screening, analytical services, etc. It also supplies SPF lab animals. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India.
The prominent promoters of Vivo Bio Tech Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
CRYPTOLOGIC SYSTEMS PRIVATE LIMITED |
7.84%
|
|
MAXCELL PHONES COMMUNICATIONS INDIA PRIVATE LIMITED |
6.99%
|
|
SHRI SHRI RESORTS PRIVATE LIMITED |
6.22%
|
|
IRAGAVARAPU CONSTRUCTIONS PRIVATE LIMITED |
5.83%
|
The chairman of the company is , and the managing director is .
There is no promoter pledging in Vivo Bio Tech Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
3,216
|
|
|
403
|
|
|
127
|
|
|
19
|
| Vivo Bio Tech Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
12.19
|
|
Operating margin(%)
|
25.3
|
|
Net Margin(%)
|
13.7
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Vivo Bio Tech Ltd was ₹7 Cr.
₹-0.74
(
